Transcenta Therapeutics (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based ...

Kathleen Elison is the co-founder and principal scientist at Terray Therapeutics, where she leads the research and ...

Abstract: As one of the great advances in modern technology, the microarray is widely used in many fields, including biomedical research, clinical diagnosis, and so on. Evidently, in order to extract ...

Abstract: Recent studies have demonstrated microarray expression data can be used to identify gene regulatory pathways. However, one of the major challenges is to utilize the large microarray data ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...

BRISBANE, Australia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering ...

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial. Continuous MMAI scores ...

According to Precedence Research, the global microarray market size was estimated at USD 5.46 billion in 2023 and is projected to reach USD 13.81 billion by 2034, registering a CAGR of 8.8% from 2024 ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...